Global Pet Inactivated Vaccine Market Research Report 2026(Status and Outlook)
Inactivated vaccines for pets are vaccines made from killed pathogens.According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly ?6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 377%.
The global Pet Inactivated Vaccine market size was estimated at USD 539.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pet Inactivated Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pet Inactivated Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pet Inactivated Vaccine market.
Global Pet Inactivated Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck Animal Health
Merial (Sanofi)
Virbac
Pfizer
Market Segmentation (by Type)
Obtained by Heat Killing
Killed by Chemical Methods such as Formaldehyde
Obtained by Radiation Killing
Market Segmentation (by Application)
Dog
Cat
Dird
Others
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pet Inactivated Vaccine Market
Overview of the regional outlook of the Pet Inactivated Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pet Inactivated Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pet Inactivated Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Pet Inactivated Vaccine market size was estimated at USD 539.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pet Inactivated Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pet Inactivated Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pet Inactivated Vaccine market.
Global Pet Inactivated Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck Animal Health
Merial (Sanofi)
Virbac
Pfizer
Market Segmentation (by Type)
Obtained by Heat Killing
Killed by Chemical Methods such as Formaldehyde
Obtained by Radiation Killing
Market Segmentation (by Application)
Dog
Cat
Dird
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pet Inactivated Vaccine Market
Overview of the regional outlook of the Pet Inactivated Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pet Inactivated Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pet Inactivated Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pet Inactivated Vaccine
1.2 Key Market Segments
1.2.1 Pet Inactivated Vaccine Segment by Type
1.2.2 Pet Inactivated Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PET INACTIVATED VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pet Inactivated Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Pet Inactivated Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PET INACTIVATED VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pet Inactivated Vaccine Product Life Cycle
3.3 Global Pet Inactivated Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Pet Inactivated Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Pet Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pet Inactivated Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Pet Inactivated Vaccine Market Competitive Situation and Trends
3.8.1 Pet Inactivated Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pet Inactivated Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PET INACTIVATED VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Pet Inactivated Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PET INACTIVATED VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pet Inactivated Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pet Inactivated Vaccine Market
5.7 ESG Ratings of Leading Companies
6 PET INACTIVATED VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pet Inactivated Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Pet Inactivated Vaccine Market Size by Type (2020-2025)
6.4 Global Pet Inactivated Vaccine Price by Type (2020-2025)
7 PET INACTIVATED VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pet Inactivated Vaccine Market Sales by Application (2020-2025)
7.3 Global Pet Inactivated Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Pet Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
8 PET INACTIVATED VACCINE MARKET SALES BY REGION
8.1 Global Pet Inactivated Vaccine Sales by Region
8.1.1 Global Pet Inactivated Vaccine Sales by Region
8.1.2 Global Pet Inactivated Vaccine Sales Market Share by Region
8.2 Global Pet Inactivated Vaccine Market Size by Region
8.2.1 Global Pet Inactivated Vaccine Market Size by Region
8.2.2 Global Pet Inactivated Vaccine Market Size by Region
8.3 North America
8.3.1 North America Pet Inactivated Vaccine Sales by Country
8.3.2 North America Pet Inactivated Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pet Inactivated Vaccine Sales by Country
8.4.2 Europe Pet Inactivated Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pet Inactivated Vaccine Sales by Region
8.5.2 Asia Pacific Pet Inactivated Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pet Inactivated Vaccine Sales by Country
8.6.2 South America Pet Inactivated Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pet Inactivated Vaccine Sales by Region
8.7.2 Middle East and Africa Pet Inactivated Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PET INACTIVATED VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Pet Inactivated Vaccine by Region(2020-2025)
9.2 Global Pet Inactivated Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Pet Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pet Inactivated Vaccine Production
9.4.1 North America Pet Inactivated Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Pet Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pet Inactivated Vaccine Production
9.5.1 Europe Pet Inactivated Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Pet Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pet Inactivated Vaccine Production (2020-2025)
9.6.1 Japan Pet Inactivated Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Pet Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pet Inactivated Vaccine Production (2020-2025)
9.7.1 China Pet Inactivated Vaccine Production Growth Rate (2020-2025)
9.7.2 China Pet Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bayer Healthcare
10.1.1 Bayer Healthcare Basic Information
10.1.2 Bayer Healthcare Pet Inactivated Vaccine Product Overview
10.1.3 Bayer Healthcare Pet Inactivated Vaccine Product Market Performance
10.1.4 Bayer Healthcare Business Overview
10.1.5 Bayer Healthcare SWOT Analysis
10.1.6 Bayer Healthcare Recent Developments
10.2 Vetoquinol S.A
10.2.1 Vetoquinol S.A Basic Information
10.2.2 Vetoquinol S.A Pet Inactivated Vaccine Product Overview
10.2.3 Vetoquinol S.A Pet Inactivated Vaccine Product Market Performance
10.2.4 Vetoquinol S.A Business Overview
10.2.5 Vetoquinol S.A SWOT Analysis
10.2.6 Vetoquinol S.A Recent Developments
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Basic Information
10.3.2 Boehringer Ingelheim Pet Inactivated Vaccine Product Overview
10.3.3 Boehringer Ingelheim Pet Inactivated Vaccine Product Market Performance
10.3.4 Boehringer Ingelheim Business Overview
10.3.5 Boehringer Ingelheim SWOT Analysis
10.3.6 Boehringer Ingelheim Recent Developments
10.4 Ceva
10.4.1 Ceva Basic Information
10.4.2 Ceva Pet Inactivated Vaccine Product Overview
10.4.3 Ceva Pet Inactivated Vaccine Product Market Performance
10.4.4 Ceva Business Overview
10.4.5 Ceva Recent Developments
10.5 Eli Lilly
10.5.1 Eli Lilly Basic Information
10.5.2 Eli Lilly Pet Inactivated Vaccine Product Overview
10.5.3 Eli Lilly Pet Inactivated Vaccine Product Market Performance
10.5.4 Eli Lilly Business Overview
10.5.5 Eli Lilly Recent Developments
10.6 Heska
10.6.1 Heska Basic Information
10.6.2 Heska Pet Inactivated Vaccine Product Overview
10.6.3 Heska Pet Inactivated Vaccine Product Market Performance
10.6.4 Heska Business Overview
10.6.5 Heska Recent Developments
10.7 Merck Animal Health
10.7.1 Merck Animal Health Basic Information
10.7.2 Merck Animal Health Pet Inactivated Vaccine Product Overview
10.7.3 Merck Animal Health Pet Inactivated Vaccine Product Market Performance
10.7.4 Merck Animal Health Business Overview
10.7.5 Merck Animal Health Recent Developments
10.8 Merial (Sanofi)
10.8.1 Merial (Sanofi) Basic Information
10.8.2 Merial (Sanofi) Pet Inactivated Vaccine Product Overview
10.8.3 Merial (Sanofi) Pet Inactivated Vaccine Product Market Performance
10.8.4 Merial (Sanofi) Business Overview
10.8.5 Merial (Sanofi) Recent Developments
10.9 Virbac
10.9.1 Virbac Basic Information
10.9.2 Virbac Pet Inactivated Vaccine Product Overview
10.9.3 Virbac Pet Inactivated Vaccine Product Market Performance
10.9.4 Virbac Business Overview
10.9.5 Virbac Recent Developments
10.10 Pfizer
10.10.1 Pfizer Basic Information
10.10.2 Pfizer Pet Inactivated Vaccine Product Overview
10.10.3 Pfizer Pet Inactivated Vaccine Product Market Performance
10.10.4 Pfizer Business Overview
10.10.5 Pfizer Recent Developments
11 PET INACTIVATED VACCINE MARKET FORECAST BY REGION
11.1 Global Pet Inactivated Vaccine Market Size Forecast
11.2 Global Pet Inactivated Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pet Inactivated Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Pet Inactivated Vaccine Market Size Forecast by Region
11.2.4 South America Pet Inactivated Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pet Inactivated Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Pet Inactivated Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Pet Inactivated Vaccine by Type (2026-2035)
12.1.2 Global Pet Inactivated Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Pet Inactivated Vaccine by Type (2026-2035)
12.2 Global Pet Inactivated Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Pet Inactivated Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Pet Inactivated Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pet Inactivated Vaccine
1.2 Key Market Segments
1.2.1 Pet Inactivated Vaccine Segment by Type
1.2.2 Pet Inactivated Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PET INACTIVATED VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pet Inactivated Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Pet Inactivated Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PET INACTIVATED VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pet Inactivated Vaccine Product Life Cycle
3.3 Global Pet Inactivated Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Pet Inactivated Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Pet Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pet Inactivated Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Pet Inactivated Vaccine Market Competitive Situation and Trends
3.8.1 Pet Inactivated Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pet Inactivated Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PET INACTIVATED VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Pet Inactivated Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PET INACTIVATED VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pet Inactivated Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pet Inactivated Vaccine Market
5.7 ESG Ratings of Leading Companies
6 PET INACTIVATED VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pet Inactivated Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Pet Inactivated Vaccine Market Size by Type (2020-2025)
6.4 Global Pet Inactivated Vaccine Price by Type (2020-2025)
7 PET INACTIVATED VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pet Inactivated Vaccine Market Sales by Application (2020-2025)
7.3 Global Pet Inactivated Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Pet Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
8 PET INACTIVATED VACCINE MARKET SALES BY REGION
8.1 Global Pet Inactivated Vaccine Sales by Region
8.1.1 Global Pet Inactivated Vaccine Sales by Region
8.1.2 Global Pet Inactivated Vaccine Sales Market Share by Region
8.2 Global Pet Inactivated Vaccine Market Size by Region
8.2.1 Global Pet Inactivated Vaccine Market Size by Region
8.2.2 Global Pet Inactivated Vaccine Market Size by Region
8.3 North America
8.3.1 North America Pet Inactivated Vaccine Sales by Country
8.3.2 North America Pet Inactivated Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pet Inactivated Vaccine Sales by Country
8.4.2 Europe Pet Inactivated Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pet Inactivated Vaccine Sales by Region
8.5.2 Asia Pacific Pet Inactivated Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pet Inactivated Vaccine Sales by Country
8.6.2 South America Pet Inactivated Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pet Inactivated Vaccine Sales by Region
8.7.2 Middle East and Africa Pet Inactivated Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PET INACTIVATED VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Pet Inactivated Vaccine by Region(2020-2025)
9.2 Global Pet Inactivated Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Pet Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pet Inactivated Vaccine Production
9.4.1 North America Pet Inactivated Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Pet Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pet Inactivated Vaccine Production
9.5.1 Europe Pet Inactivated Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Pet Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pet Inactivated Vaccine Production (2020-2025)
9.6.1 Japan Pet Inactivated Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Pet Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pet Inactivated Vaccine Production (2020-2025)
9.7.1 China Pet Inactivated Vaccine Production Growth Rate (2020-2025)
9.7.2 China Pet Inactivated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bayer Healthcare
10.1.1 Bayer Healthcare Basic Information
10.1.2 Bayer Healthcare Pet Inactivated Vaccine Product Overview
10.1.3 Bayer Healthcare Pet Inactivated Vaccine Product Market Performance
10.1.4 Bayer Healthcare Business Overview
10.1.5 Bayer Healthcare SWOT Analysis
10.1.6 Bayer Healthcare Recent Developments
10.2 Vetoquinol S.A
10.2.1 Vetoquinol S.A Basic Information
10.2.2 Vetoquinol S.A Pet Inactivated Vaccine Product Overview
10.2.3 Vetoquinol S.A Pet Inactivated Vaccine Product Market Performance
10.2.4 Vetoquinol S.A Business Overview
10.2.5 Vetoquinol S.A SWOT Analysis
10.2.6 Vetoquinol S.A Recent Developments
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Basic Information
10.3.2 Boehringer Ingelheim Pet Inactivated Vaccine Product Overview
10.3.3 Boehringer Ingelheim Pet Inactivated Vaccine Product Market Performance
10.3.4 Boehringer Ingelheim Business Overview
10.3.5 Boehringer Ingelheim SWOT Analysis
10.3.6 Boehringer Ingelheim Recent Developments
10.4 Ceva
10.4.1 Ceva Basic Information
10.4.2 Ceva Pet Inactivated Vaccine Product Overview
10.4.3 Ceva Pet Inactivated Vaccine Product Market Performance
10.4.4 Ceva Business Overview
10.4.5 Ceva Recent Developments
10.5 Eli Lilly
10.5.1 Eli Lilly Basic Information
10.5.2 Eli Lilly Pet Inactivated Vaccine Product Overview
10.5.3 Eli Lilly Pet Inactivated Vaccine Product Market Performance
10.5.4 Eli Lilly Business Overview
10.5.5 Eli Lilly Recent Developments
10.6 Heska
10.6.1 Heska Basic Information
10.6.2 Heska Pet Inactivated Vaccine Product Overview
10.6.3 Heska Pet Inactivated Vaccine Product Market Performance
10.6.4 Heska Business Overview
10.6.5 Heska Recent Developments
10.7 Merck Animal Health
10.7.1 Merck Animal Health Basic Information
10.7.2 Merck Animal Health Pet Inactivated Vaccine Product Overview
10.7.3 Merck Animal Health Pet Inactivated Vaccine Product Market Performance
10.7.4 Merck Animal Health Business Overview
10.7.5 Merck Animal Health Recent Developments
10.8 Merial (Sanofi)
10.8.1 Merial (Sanofi) Basic Information
10.8.2 Merial (Sanofi) Pet Inactivated Vaccine Product Overview
10.8.3 Merial (Sanofi) Pet Inactivated Vaccine Product Market Performance
10.8.4 Merial (Sanofi) Business Overview
10.8.5 Merial (Sanofi) Recent Developments
10.9 Virbac
10.9.1 Virbac Basic Information
10.9.2 Virbac Pet Inactivated Vaccine Product Overview
10.9.3 Virbac Pet Inactivated Vaccine Product Market Performance
10.9.4 Virbac Business Overview
10.9.5 Virbac Recent Developments
10.10 Pfizer
10.10.1 Pfizer Basic Information
10.10.2 Pfizer Pet Inactivated Vaccine Product Overview
10.10.3 Pfizer Pet Inactivated Vaccine Product Market Performance
10.10.4 Pfizer Business Overview
10.10.5 Pfizer Recent Developments
11 PET INACTIVATED VACCINE MARKET FORECAST BY REGION
11.1 Global Pet Inactivated Vaccine Market Size Forecast
11.2 Global Pet Inactivated Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pet Inactivated Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Pet Inactivated Vaccine Market Size Forecast by Region
11.2.4 South America Pet Inactivated Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pet Inactivated Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Pet Inactivated Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Pet Inactivated Vaccine by Type (2026-2035)
12.1.2 Global Pet Inactivated Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Pet Inactivated Vaccine by Type (2026-2035)
12.2 Global Pet Inactivated Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Pet Inactivated Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Pet Inactivated Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pet Inactivated Vaccine Market Size by Type (M USD)
Table 4. Global Pet Inactivated Vaccine Market Size by Application
Table 5. Pet Inactivated Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Pet Inactivated Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Pet Inactivated Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pet Inactivated Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pet Inactivated Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Inactivated Vaccine as of 2025)
Table 11. Global Market Pet Inactivated Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Pet Inactivated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pet Inactivated Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pet Inactivated Vaccine Sales by Type (K MT)
Table 27. Global Pet Inactivated Vaccine Market Size by Type (M USD)
Table 28. Global Pet Inactivated Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Pet Inactivated Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Pet Inactivated Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Pet Inactivated Vaccine Market Share by Type (2020-2025)
Table 32. Global Pet Inactivated Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Pet Inactivated Vaccine Sales (K MT) by Application
Table 34. Global Pet Inactivated Vaccine Market Size by Application
Table 35. Global Pet Inactivated Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Pet Inactivated Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Pet Inactivated Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pet Inactivated Vaccine Market Share by Application (2020-2025)
Table 39. Global Pet Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Pet Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Pet Inactivated Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Pet Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pet Inactivated Vaccine Market Size by Region (2020-2025)
Table 44. North America Pet Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Pet Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pet Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Pet Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pet Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Pet Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pet Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Pet Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pet Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Pet Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pet Inactivated Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Pet Inactivated Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pet Inactivated Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Pet Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Pet Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Pet Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Pet Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Pet Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Bayer Healthcare Basic Information
Table 63. Bayer Healthcare Pet Inactivated Vaccine Product Overview
Table 64. Bayer Healthcare Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Bayer Healthcare Business Overview
Table 66. Bayer Healthcare SWOT Analysis
Table 67. Bayer Healthcare Recent Developments
Table 68. Vetoquinol S.A Basic Information
Table 69. Vetoquinol S.A Pet Inactivated Vaccine Product Overview
Table 70. Vetoquinol S.A Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Vetoquinol S.A Business Overview
Table 72. Vetoquinol S.A SWOT Analysis
Table 73. Vetoquinol S.A Recent Developments
Table 74. Boehringer Ingelheim Basic Information
Table 75. Boehringer Ingelheim Pet Inactivated Vaccine Product Overview
Table 76. Boehringer Ingelheim Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Boehringer Ingelheim Business Overview
Table 78. Boehringer Ingelheim SWOT Analysis
Table 79. Boehringer Ingelheim Recent Developments
Table 80. Ceva Basic Information
Table 81. Ceva Pet Inactivated Vaccine Product Overview
Table 82. Ceva Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Ceva Business Overview
Table 84. Ceva Recent Developments
Table 85. Eli Lilly Basic Information
Table 86. Eli Lilly Pet Inactivated Vaccine Product Overview
Table 87. Eli Lilly Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Recent Developments
Table 90. Heska Basic Information
Table 91. Heska Pet Inactivated Vaccine Product Overview
Table 92. Heska Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Heska Business Overview
Table 94. Heska Recent Developments
Table 95. Merck Animal Health Basic Information
Table 96. Merck Animal Health Pet Inactivated Vaccine Product Overview
Table 97. Merck Animal Health Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Merck Animal Health Business Overview
Table 99. Merck Animal Health Recent Developments
Table 100. Merial (Sanofi) Basic Information
Table 101. Merial (Sanofi) Pet Inactivated Vaccine Product Overview
Table 102. Merial (Sanofi) Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Merial (Sanofi) Business Overview
Table 104. Merial (Sanofi) Recent Developments
Table 105. Virbac Basic Information
Table 106. Virbac Pet Inactivated Vaccine Product Overview
Table 107. Virbac Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Virbac Business Overview
Table 109. Virbac Recent Developments
Table 110. Pfizer Basic Information
Table 111. Pfizer Pet Inactivated Vaccine Product Overview
Table 112. Pfizer Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Pfizer Business Overview
Table 114. Pfizer Recent Developments
Table 115. Global Pet Inactivated Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Pet Inactivated Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Pet Inactivated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Pet Inactivated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Pet Inactivated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Pet Inactivated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Pet Inactivated Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Pet Inactivated Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Pet Inactivated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Pet Inactivated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Pet Inactivated Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Pet Inactivated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Pet Inactivated Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Pet Inactivated Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Pet Inactivated Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Pet Inactivated Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Pet Inactivated Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pet Inactivated Vaccine Market Size by Type (M USD)
Table 4. Global Pet Inactivated Vaccine Market Size by Application
Table 5. Pet Inactivated Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Pet Inactivated Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Pet Inactivated Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pet Inactivated Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pet Inactivated Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Inactivated Vaccine as of 2025)
Table 11. Global Market Pet Inactivated Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Pet Inactivated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pet Inactivated Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pet Inactivated Vaccine Sales by Type (K MT)
Table 27. Global Pet Inactivated Vaccine Market Size by Type (M USD)
Table 28. Global Pet Inactivated Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Pet Inactivated Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Pet Inactivated Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Pet Inactivated Vaccine Market Share by Type (2020-2025)
Table 32. Global Pet Inactivated Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Pet Inactivated Vaccine Sales (K MT) by Application
Table 34. Global Pet Inactivated Vaccine Market Size by Application
Table 35. Global Pet Inactivated Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Pet Inactivated Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Pet Inactivated Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pet Inactivated Vaccine Market Share by Application (2020-2025)
Table 39. Global Pet Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Pet Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Pet Inactivated Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Pet Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pet Inactivated Vaccine Market Size by Region (2020-2025)
Table 44. North America Pet Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Pet Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pet Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Pet Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pet Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Pet Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pet Inactivated Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Pet Inactivated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pet Inactivated Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Pet Inactivated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pet Inactivated Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Pet Inactivated Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pet Inactivated Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Pet Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Pet Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Pet Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Pet Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Pet Inactivated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Bayer Healthcare Basic Information
Table 63. Bayer Healthcare Pet Inactivated Vaccine Product Overview
Table 64. Bayer Healthcare Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Bayer Healthcare Business Overview
Table 66. Bayer Healthcare SWOT Analysis
Table 67. Bayer Healthcare Recent Developments
Table 68. Vetoquinol S.A Basic Information
Table 69. Vetoquinol S.A Pet Inactivated Vaccine Product Overview
Table 70. Vetoquinol S.A Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Vetoquinol S.A Business Overview
Table 72. Vetoquinol S.A SWOT Analysis
Table 73. Vetoquinol S.A Recent Developments
Table 74. Boehringer Ingelheim Basic Information
Table 75. Boehringer Ingelheim Pet Inactivated Vaccine Product Overview
Table 76. Boehringer Ingelheim Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Boehringer Ingelheim Business Overview
Table 78. Boehringer Ingelheim SWOT Analysis
Table 79. Boehringer Ingelheim Recent Developments
Table 80. Ceva Basic Information
Table 81. Ceva Pet Inactivated Vaccine Product Overview
Table 82. Ceva Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Ceva Business Overview
Table 84. Ceva Recent Developments
Table 85. Eli Lilly Basic Information
Table 86. Eli Lilly Pet Inactivated Vaccine Product Overview
Table 87. Eli Lilly Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Recent Developments
Table 90. Heska Basic Information
Table 91. Heska Pet Inactivated Vaccine Product Overview
Table 92. Heska Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Heska Business Overview
Table 94. Heska Recent Developments
Table 95. Merck Animal Health Basic Information
Table 96. Merck Animal Health Pet Inactivated Vaccine Product Overview
Table 97. Merck Animal Health Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Merck Animal Health Business Overview
Table 99. Merck Animal Health Recent Developments
Table 100. Merial (Sanofi) Basic Information
Table 101. Merial (Sanofi) Pet Inactivated Vaccine Product Overview
Table 102. Merial (Sanofi) Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Merial (Sanofi) Business Overview
Table 104. Merial (Sanofi) Recent Developments
Table 105. Virbac Basic Information
Table 106. Virbac Pet Inactivated Vaccine Product Overview
Table 107. Virbac Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Virbac Business Overview
Table 109. Virbac Recent Developments
Table 110. Pfizer Basic Information
Table 111. Pfizer Pet Inactivated Vaccine Product Overview
Table 112. Pfizer Pet Inactivated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Pfizer Business Overview
Table 114. Pfizer Recent Developments
Table 115. Global Pet Inactivated Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Pet Inactivated Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Pet Inactivated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Pet Inactivated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Pet Inactivated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Pet Inactivated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Pet Inactivated Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Pet Inactivated Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Pet Inactivated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Pet Inactivated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Pet Inactivated Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Pet Inactivated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Pet Inactivated Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Pet Inactivated Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Pet Inactivated Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Pet Inactivated Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Pet Inactivated Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pet Inactivated Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pet Inactivated Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Pet Inactivated Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Pet Inactivated Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pet Inactivated Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pet Inactivated Vaccine Product Life Cycle
Figure 13. Pet Inactivated Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Pet Inactivated Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Pet Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pet Inactivated Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pet Inactivated Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Pet Inactivated Vaccine
Figure 19. Global Pet Inactivated Vaccine Market PEST Analysis
Figure 20. Global Pet Inactivated Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pet Inactivated Vaccine Market Share by Type
Figure 27. Sales Market Share of Pet Inactivated Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Pet Inactivated Vaccine by Type in 2025
Figure 29. Market Share of Pet Inactivated Vaccine by Type (2020-2025)
Figure 30. Market Share of Pet Inactivated Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pet Inactivated Vaccine Market Share by Application
Figure 33. Global Pet Inactivated Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Pet Inactivated Vaccine Sales Market Share by Application in 2025
Figure 35. Global Pet Inactivated Vaccine Market Share by Application (2020-2025)
Figure 36. Global Pet Inactivated Vaccine Market Share by Application in 2025
Figure 37. Global Pet Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pet Inactivated Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Pet Inactivated Vaccine Market Size by Region (2020-2025)
Figure 40. North America Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Pet Inactivated Vaccine Sales Market Share by Country in 2024
Figure 43. North America Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pet Inactivated Vaccine Market Size by Country in 2024
Figure 45. U.S. Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pet Inactivated Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Pet Inactivated Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pet Inactivated Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pet Inactivated Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Pet Inactivated Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pet Inactivated Vaccine Market Size by Country in 2024
Figure 55. Germany Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pet Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Pet Inactivated Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pet Inactivated Vaccine Market Size by Region in 2024
Figure 68. China Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pet Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Pet Inactivated Vaccine Sales Market Share by Country in 2024
Figure 80. South America Pet Inactivated Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Pet Inactivated Vaccine Market Size by Country in 2024
Figure 82. Brazil Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pet Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Pet Inactivated Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pet Inactivated Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pet Inactivated Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pet Inactivated Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Pet Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Pet Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Pet Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Pet Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Pet Inactivated Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Pet Inactivated Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pet Inactivated Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pet Inactivated Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Pet Inactivated Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Pet Inactivated Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Pet Inactivated Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pet Inactivated Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Pet Inactivated Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Pet Inactivated Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pet Inactivated Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pet Inactivated Vaccine Product Life Cycle
Figure 13. Pet Inactivated Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Pet Inactivated Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Pet Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pet Inactivated Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pet Inactivated Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Pet Inactivated Vaccine
Figure 19. Global Pet Inactivated Vaccine Market PEST Analysis
Figure 20. Global Pet Inactivated Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pet Inactivated Vaccine Market Share by Type
Figure 27. Sales Market Share of Pet Inactivated Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Pet Inactivated Vaccine by Type in 2025
Figure 29. Market Share of Pet Inactivated Vaccine by Type (2020-2025)
Figure 30. Market Share of Pet Inactivated Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pet Inactivated Vaccine Market Share by Application
Figure 33. Global Pet Inactivated Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Pet Inactivated Vaccine Sales Market Share by Application in 2025
Figure 35. Global Pet Inactivated Vaccine Market Share by Application (2020-2025)
Figure 36. Global Pet Inactivated Vaccine Market Share by Application in 2025
Figure 37. Global Pet Inactivated Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pet Inactivated Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Pet Inactivated Vaccine Market Size by Region (2020-2025)
Figure 40. North America Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Pet Inactivated Vaccine Sales Market Share by Country in 2024
Figure 43. North America Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pet Inactivated Vaccine Market Size by Country in 2024
Figure 45. U.S. Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pet Inactivated Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Pet Inactivated Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pet Inactivated Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pet Inactivated Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Pet Inactivated Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pet Inactivated Vaccine Market Size by Country in 2024
Figure 55. Germany Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pet Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Pet Inactivated Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pet Inactivated Vaccine Market Size by Region in 2024
Figure 68. China Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pet Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Pet Inactivated Vaccine Sales Market Share by Country in 2024
Figure 80. South America Pet Inactivated Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Pet Inactivated Vaccine Market Size by Country in 2024
Figure 82. Brazil Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pet Inactivated Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Pet Inactivated Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pet Inactivated Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pet Inactivated Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pet Inactivated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Pet Inactivated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pet Inactivated Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Pet Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Pet Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Pet Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Pet Inactivated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Pet Inactivated Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Pet Inactivated Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pet Inactivated Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pet Inactivated Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Pet Inactivated Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Pet Inactivated Vaccine Market Share Forecast by Application (2026-2035)
